先进的糖化终端产品通过激活mTOR-ATF4正反循环来促进半径化
Sheng Yang1,2, JiaJun Xie1, ZhiJie Pan1,3
1Division of Orthopaedic Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Experimental & molecular medicine
|February 29, 2024
概括
针对先进的糖化终产物 (AGEs) 和它们的受体 (RAGEs),可以治疗半径化. 这一途径通过ATF4-mTOR反循环促进骨质生成,为膝关节关节炎 (KOA) 提供新的治疗点.
科学领域:
- 生物化学 生物化学
- 整形外科 整形外科 整形外科
- 细胞生物学 细胞生物学
背景情况:
- 阴茎化是膝关节骨关节炎 (KOA) 的早期症状,影响膝关节功能.
- 阴茎化与血管化具有生化相似之处,涉及先进的糖化终产物 (AGEs) 和它们的受体 (RAGEs).
研究的目的:
- 调查 AGE-RAGE 途径在半径化中的作用.
- 确定针对 AGE-RAGE 是否可以作为治疗半月膜化和KOA的治疗策略.
主要方法:
- 研究了AGE-RAGE对阴茎细胞骨质生成和化的影响.
- 利用分子生物学技术来阐明下游的信号通路,包括mTOR和ATF4.
主要成果:
- 发现 AGE-RAGE 信号促进阴茎细胞骨质生成,并加剧阴茎化.
- AGE-RAGE激活mTOR和ATF4,创建一个积极的反循环,增强骨质生成能力.
- mTOR抑制了ATF4的降解,而ATF4增加了阿金氨酸的吸收,以激活mTOR.
结论:
- AGE-RAGE通路在半径化中起着重要作用.
- 积极的ATF4-mTOR反循环对于阴茎细胞骨质生成至关重要.
- 针对AGE-RAGE路径和ATF4-mTOR循环,为KOA提供了潜在的治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
cAMP-dependent Protein Kinase Pathways
6.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K


